Nathan Steven D 4

What Happened

• Nathan Steven D, a director of Gossamer Bio, was granted a derivative award covering 115,000 shares on 2026-06-04. The reported acquisition price is $0.00, and no cash was exchanged at grant. This is an award (code A) under the company's non‑employee director compensation program—not a market purchase or sale.

Key Details

• Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
• Amount: 115,000 shares; reported price: $0.00; transaction type: Award/Grant (derivative security).
• Vesting/exercisability (footnote): the entire award becomes fully vested and exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next annual meeting, subject to continued board service.
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnote: grant made pursuant to the Non‑Employee Director Compensation Program.

Context

• Director awards like this are routine compensation for board service and do not involve an immediate open‑market trade. Because this is a derivative award that only vests/exercises later, it does not necessarily signal an immediate change in insider sentiment. Retail investors should view this as standard director compensation unless followed by later exercises or sales.